GENOXAL INYECTABLE for B-cell lymphoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 15 adverse event reports in the FDA FAERS database where GENOXAL INYECTABLE was used for B-cell lymphoma.
Most Reported Side Effects for GENOXAL INYECTABLE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Graft versus host disease | 43 | 45.7% | 3 | 0 |
| Recurrent cancer | 13 | 13.8% | 13 | 0 |
| Disease progression | 12 | 12.8% | 7 | 0 |
| Death | 11 | 11.7% | 11 | 0 |
| Disease recurrence | 7 | 7.5% | 0 | 0 |
Other Indications for GENOXAL INYECTABLE
Other Drugs Used for B-cell lymphoma
RITUXIMAB (7,811)
CYCLOPHOSPHAMIDE (4,766)
VINCRISTINE (4,346)
DOXORUBICIN (3,947)
LENALIDOMIDE (3,474)
PREDNISONE (2,561)
BENDAMUSTINE (1,668)
PREDNISOLONE (1,489)
ETOPOSIDE (1,268)
IDELALISIB (1,240)